Literature DB >> 23678213

Predicting early death after cardiovascular surgery by using the Texas Heart Institute Risk Scoring Technique (THIRST).

Saurabh Sanon1, Vei-Vei Lee, MacArthur A Elayda, Sreedevi Gondi, James J Livesay, George J Reul, James M Wilson.   

Abstract

Preoperative risk-prediction models are an important tool in contemporary surgical practice. We developed a risk-scoring technique for predicting in-hospital death for cardiovascular surgery patients. From our institutional database, we obtained data on 21,120 patients admitted from 1995 through 2007. The outcome of interest was early death (in-hospital or within 30 days of surgery). To identify mortality predictors, multivariate logistic regression was performed on data from 14,030 patients from 1995 through 2002 and risk scores were computed to stratify patients (low-, medium-, and high-risk). A recalibrated model was then created from the original risk scores and validated on data from 7,090 patients from 2003 through 2007. Significant predictors of death included urgent surgery within 48 hours of admission, advanced age, renal insufficiency, repeat coronary artery bypass grafting, repeat aortic aneurysm repair, concomitant aortic aneurysm or left ventricular aneurysm repair with coronary bypass or valvular surgery, and preoperative intra-aortic balloon pump support. Because the original model overpredicted death for operations performed from 2003 through 2007, this was adjusted for by applying the recalibrated model. Applying the recalibrated model to the validation set revealed predicted mortality rates of 1.7%, 4.2%, and 13.4% and observed rates of 1.1%, 5.1%, and 13%, respectively. Because our model discriminates risk groups by using preoperative clinical criteria alone, it can be a useful bedside tool for identifying patients at greater risk of early death after cardiovascular surgery, thereby facilitating clinical decision-making. The model can be recalibrated for use in other types of patient populations.

Entities:  

Keywords:  Cardiac surgical procedures/mortality; ROC curve; United States/epidemiology; evaluation studies as topic; hospital mortality; logistic models; models, statistical; outcome assessment (health care)/methods; predictive value of tests; regression analysis of tests; risk assessment/classification/methods/statistics & numerical data; risk factors; statistics as topic

Mesh:

Year:  2013        PMID: 23678213      PMCID: PMC3649797     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  25 in total

1.  Validation of the 2000 Bernstein-Parsonnet score versus the EuroSCORE as a prognostic tool in cardiac surgery.

Authors:  Marius Berman; Alon Stamler; Gideon Sahar; Georgios P Georghiou; Erez Sharoni; Ron Brauner; Benjamin Medalion; Bernardo A Vidne; Alexander Kogan
Journal:  Ann Thorac Surg       Date:  2006-02       Impact factor: 4.330

2.  Prediction for major adverse outcomes in cardiac surgery: comparison of three prediction models.

Authors:  Cheng-Hung Hsieh; Shih-Kuei Peng; Tzung-Chieh Tsai; Yi-Ru Shih; Shih-Yen Peng
Journal:  J Formos Med Assoc       Date:  2007-09       Impact factor: 3.282

Review 3.  Performance of EuroSCORE in CABG and off-pump coronary artery bypass grafting: single institution experience and meta-analysis.

Authors:  Alessandro Parolari; Lorenzo L Pesce; Matteo Trezzi; Claudia Loardi; Samer Kassem; Claudio Brambillasca; Bruno Miguel; Elena Tremoli; Paolo Biglioli; Francesco Alamanni
Journal:  Eur Heart J       Date:  2009-01-13       Impact factor: 29.983

4.  European system for cardiac operative risk evaluation (EuroSCORE).

Authors:  S A Nashef; F Roques; P Michel; E Gauducheau; S Lemeshow; R Salamon
Journal:  Eur J Cardiothorac Surg       Date:  1999-07       Impact factor: 4.191

5.  Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction.

Authors:  D C Lee; M C Oz; A D Weinberg; S X Lin; W Ting
Journal:  Ann Thorac Surg       Date:  2001-04       Impact factor: 4.330

6.  Risk-prediction models for mortality after coronary artery bypass surgery: application to individual patients.

Authors:  Pankaj Madan; MacArthur A Elayda; Vei-Vei Lee; James M Wilson
Journal:  Int J Cardiol       Date:  2010-03-04       Impact factor: 4.164

7.  The performance of the EuroSCORE and the Society of Thoracic Surgeons mortality risk score: the gender factor.

Authors:  Niv Ad; Scott D Barnett; Alan M Speir
Journal:  Interact Cardiovasc Thorac Surg       Date:  2007-01-11

8.  Validation of the EuroSCORE model in Australia.

Authors:  Cheng-Hon Yap; Christopher Reid; Michael Yii; Michael A Rowland; Morteza Mohajeri; Peter D Skillington; Siven Seevanayagam; Julian A Smith
Journal:  Eur J Cardiothorac Surg       Date:  2006-02-13       Impact factor: 4.191

9.  The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.

Authors:  David M Shahian; Sean M O'Brien; Giovanni Filardo; Victor A Ferraris; Constance K Haan; Jeffrey B Rich; Sharon-Lise T Normand; Elizabeth R DeLong; Cynthia M Shewan; Rachel S Dokholyan; Eric D Peterson; Fred H Edwards; Richard P Anderson
Journal:  Ann Thorac Surg       Date:  2009-07       Impact factor: 4.330

10.  Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database.

Authors:  Rajendra H Mehta; Joshua D Grab; Sean M O'Brien; Donald D Glower; Constance K Haan; James S Gammie; Eric D Peterson
Journal:  Circulation       Date:  2008-02-04       Impact factor: 29.690

View more
  2 in total

1.  Influence of humanized care on self-efficacy, sleep and quality of life of patients in cardiovascular surgery intensive care unit.

Authors:  Zhihui Zeng; Yuzhen Guan
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Chronic Obstructive Pulmonary Disease and Off-Pump Coronary Surgery.

Authors:  Cengiz Ovalı; Aykut Şahin
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-05-18       Impact factor: 1.520

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.